Success Metrics

Clinical Success Rate
88.2%

Based on 15 completed trials

Completion Rate
88%(15/17)
Active Trials
1(5%)
Results Posted
33%(5 trials)
Terminated
2(10%)

Phase Distribution

Ph phase_3
4
20%
Ph phase_1
4
20%
Ph not_applicable
2
10%
Ph phase_4
5
25%
Ph phase_2
5
25%

Phase Distribution

4

Early Stage

5

Mid Stage

9

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
4(20.0%)
Phase 2Efficacy & side effects
5(25.0%)
Phase 3Large-scale testing
4(20.0%)
Phase 4Post-market surveillance
5(25.0%)
N/ANon-phased studies
2(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.2%

15 of 17 finished

Non-Completion Rate

11.8%

2 ended early

Currently Active

1

trials recruiting

Total Trials

20

all time

Status Distribution
Active(2)
Completed(15)
Terminated(2)
Other(1)

Detailed Status

Completed15
Terminated2
Not yet recruiting1
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
1
Success Rate
88.2%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (20.0%)
Phase 25 (25.0%)
Phase 34 (20.0%)
Phase 45 (25.0%)
N/A2 (10.0%)

Trials by Status

completed1575%
not_yet_recruiting15%
terminated210%
unknown15%
recruiting15%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT07391501Phase 4

Nitroglycerin Ointment for Pain Relief After Endoscopic Hemorrhoid Band Ligation

Not Yet Recruiting
NCT03363763Phase 2

Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex

Terminated
NCT06075264Phase 2

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

Recruiting
NCT06013371Phase 2

PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea

Terminated
NCT05487963Phase 1

Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic Dermatitis

Completed
NCT05245578Phase 1

Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects

Completed
NCT04273997Phase 2

Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds

Unknown
NCT03868098Phase 4

Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis

Completed
NCT03343509Phase 4

Topical Versus Oral Metronidazole Following Excisional Haemorrhoidectomy

Completed
NCT03304873Phase 3

Retapamulin as a Decolonizing Agent for MRSA

Completed
NCT02499484Not Applicable

Topical Glyceryl Trinitrate (GTN) and Eccentric Exercises in the Treatment of Midportion Achilles Tendinopathy

Completed
NCT02828241Phase 2

A Study to Assess the Efficacy, Safety and Tolerability of DFD-04

Completed
NCT00684177Phase 3

Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL)

Completed
NCT02334787Phase 1

A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects

Completed
NCT01598909Not Applicable

Efficacy of Arnica D1 Ointment After Upper Blepharoplasty

Completed
NCT00801879Phase 4

Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection

Completed
NCT00667056Phase 4

Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis

Completed
NCT00480896Phase 3

Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

Completed
NCT00480610Phase 3

Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment

Completed
NCT01404338Phase 1

Assessment for Tachyphylaxis to Topical Corticosteroids in the Treatment of Psoriasis

Completed

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20